Part D Plans Need Mandatory Generic Programs Without Carve-Outs – GPhA
Executive Summary
The Centers for Medicare & Medicaid Services should require Medicare prescription drug plans to implement mandatory generic drug substitution programs that do not contain "carve-outs" for certain classes of brand drugs, the Generic Pharmaceutical Association said
You may also be interested in...
USP Model Is “Starting Point”; CMS Formulary Standards Will Be True Test
U.S. Pharmacopeia's model drug classification system is only a "starting point" in developing a Medicare formulary that will pass muster with the Centers for Medicare & Medicaid Services
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: